"10.1371_journal.pone.0059681","plos one","2013-04-02T00:00:00Z","Marc Rondy; Joan Puig-Barbera; Odile Launay; Xavier Duval; Jesús Castilla; Marcela Guevara; Simona Costanzo; Katleen de Gaetano Donati; Alain Moren","EpiConcept, Paris, France; Centro Superior de Investigación en Salud Pública (CSISP), Valencia, Spain; Centro de Salud Pública de Castellón, Castellón, Spain; Institut national de la santé et de la recherche médicale (Inserm), Réseau National dInvestigation Clinique en Vaccinologie (REIVAC), Paris, France; Université Paris Descartes, Paris, France; Inserm, Centre dinvestigation Clinique (CIC) de Vaccinologie Cochin Pasteur BT505, Paris, France; Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France; Inserm, CIC 007; AP-HP, Hôpital Bichat Claude Bernard, Paris, France; Instituto de Salud Pública de Navarra, Pamplona, Spain; Centros de Investigación Biomédica en Red (CIBER), Epidemiología y Salud Pública, Barcelona, Spain; Laboratory of Genetic and Environmental Epidemiology, Research Laboratories, Fondazione di Ricerca e Cura Giovanni Paolo II, Campobasso, Italy; Department of Infectious Disease, Catholic University, Rome, Italy","Reviewed the manuscript: OL XD JC MG SC KdG. Conceived and designed the experiments: MR JPB OL JC SC AM. Performed the experiments: JPB OL XD JC MG SC KdG. Analyzed the data: MR JPB JC SC. Wrote the paper: MR JPB AM.","The following study sites received funding from vaccine producers to perform the study: Valencia and France from Sanofi Pasteur and Sanofi Pasteur MSD, Italy from GlaxoSmithKline. The pooled analysis was co-funded by the Sanofi Pasteur, Sanofi Pasteur MSD, GlaxoSmithKline and EpiConcept. The funders had no role in the pooled study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, be assured that the authors declared conflicts of interest do not alter their adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Marc Rondy","MR",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
